IL17A and peeling skin syndrome: However, we believe that the present data unmasked a novel aspect of disease pathogenesis, providing the basis for further investigation on this issue in larger patient cohorts and identifying another possible rationale for therapeutic targeting of IL‐17 in pSS 28.